(secondQuint)Safety of Intravenous Lidocaine Infusions.

 Eligibility Criteria: Adults > 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.

 Outcome measures: All side effects spontaneously reported.

 Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.

 Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.

.

 Safety of Intravenous Lidocaine Infusions@highlight

The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.

